Latest News

• Alkermes Reports Third Quarter Fiscal 2010 Financial Results Continue Reading »
• Alkermes Unveils Long-Acting Injectable Proprietary Platform for Treatment of Schizophrenia and Other CNS Disorders Continue Reading »
• Alkermes' Corporate Presentation to be Webcast at the BIO CEO & Investor Conference Continue Reading »